ANZCHOG Australian Children's Cancer Trails
Sign in
Forgot password
Home
Trials
Diseases
All Tumour Types
Bone marrow transplant
Brain and Spinal Tumours
Leukaemia
Lymphoma
Non cancer haematology
Solid tumours
About Us
Links
FAQ
Keyword or Protocol ID
View all trials
Disease
All diseases
All Tumour Types
Bone marrow transplant
Brain and Spinal Tumours
Leukaemia
Lymphoma
Non cancer haematology
Solid tumours
Location
All locations
Children's Hospital at Westmead
Christchurch Hospital
John Hunter Children's Hospital
Lady Cilento Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Princess Margaret Hospital
Queensland Children's Hospital
Royal Children's Hospital Melbourne
Royal Hobart Hospital
Starship Children's Hospital
Sydney Children's Hospital
Women and Children's Hospital
Yet to be confirmed
Advanced search
Home
/
Trials
/
Trial
Are you a member? Sign in above to view additional information
Study title
Phase I/Ib trial of combined 5’azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumors
Protocol ID
COZMOS (OZM-077)
Disease
Disease Type
Disease Subtype
Brain and Spinal Tumours
Ependymoma
Eligibility criteria
https://clinicaltrials.gov/ct2/show/NCT03206021?term=NCT03206021&rank=1
Study Status
Open
Location(s)
Monash Children's Hospital
Centre Study Status:
Open
Notes:
Perth Children's Hospital
Centre Study Status:
Open
Notes:
Royal Children's Hospital Melbourne
Centre Study Status:
Open
Notes:
Phase
Phase 1
Study type
Treatment
Diagnosis stage
Relapse/refractory
Study open date
01/09/2019
Study close date
31/12/2021
Study chair
Jordan Hansford
Sponsor
Hospital for Sick Children, Toronto, Canada
Back to search results